日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PRPS2 enhances RNA m(6)A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms.

PRPS2 通过酶依赖性和非酶依赖性机制刺激 SAM 合成,从而增强 RNA m(6)A 甲基化

Zhang Lin, Zhao Xian, Hu Jingyan, Li Tingting, Chen Hong-Zhuan, Zhang Ao, Wang Hao, Yu Jianxiu, Zhang Liang

A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy.

自组装LYTAC介导CTGF降解并重塑炎症性肿瘤微环境,用于三阴性乳腺癌治疗

Lin Jia-Yi, Wu Ye, Liang Xiao-Hui, Tang Min, Sun Xin, Lu Sheng-Xin, Jin Jin-Mei, Guo Xin, Wang Bei, Chen Hong-Zhuan, Zhang Wei-Dong, Luan Xin

Targeting metabolism to enhance immunotherapy within tumor microenvironment

靶向代谢以增强肿瘤微环境中的免疫疗法

Liang, Xiao-Hui; Chen, Xin-Yi; Yan, Yue; Cheng, Ao-Yu; Lin, Jia-Yi; Jiang, Yi-Xin; Chen, Hong-Zhuan; Jin, Jin-Mei; Luan, Xin

Erratum: Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum

勘误:醛脱氢酶 1A1 通过促进肺腺癌中活性氧-活性羰基化合物代谢途径赋予厄洛替尼耐药性:勘误

Lei, Hui-Min; Zhang, Ke-Ren; Wang, Cong Hui; Wang, Yang; Zhuang, Guang-Lei; Lu, Li-Ming; Zhang, Jian; Shen, Ying; Chen, Hong-Zhuan; Zhu, Liang

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

肿瘤代谢重塑:用于癌症免疫疗法的纳米药物

Dong, Xiao; Xia, Shu; Du, Shubo; Zhu, Mao-Hua; Lai, Xing; Yao, Shao Q; Chen, Hong-Zhuan; Fang, Chao

Correction to: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis

更正:HuR稳定的lncRNA-HGBC通过调控miR-502-3p/SET/AKT轴促进胆囊癌进展

Hu, Yun-Ping; Jin, Yun-Peng; Wu, Xiang-Song; Yang, Yang; Li, Yong-Sheng; Li, Huai-Feng; Xiang, Shan-Shan; Song, Xiao-Ling; Jiang, Lin; Zhang, Yi-Jian; Huang, Wen; Chen, Shi-Li; Liu, Fa-Tao; Chen, Chen; Zhu, Qin; Chen, Hong-Zhuan; Shao, Rong; Liu, Ying-Bin

Erratum: Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

勘误:通过抑制磷酸甘油酸脱氢酶克服EGFR突变阳性肺腺癌的厄洛替尼耐药性:勘误

Dong, Jiang-Kai; Lei, Hui-Min; Liang, Qian; Tang, Ya-Bin; Zhou, Ye; Wang, Yang; Zhang, Shengzhe; Li, Wen-Bin; Tong, Yunguang; Zhuang, Guanglei; Zhang, Liang; Chen, Hong-Zhuan; Zhu, Liang; Shen, Ying

Cytotoxic and antitumor peptides as novel chemotherapeutics

细胞毒性肽和抗肿瘤肽作为新型化疗药物

Luan, Xin; Wu, Ye; Shen, Yi-Wen; Zhang, Hong; Zhou, Yu-Dong; Chen, Hong-Zhuan; Nagle, Dale G; Zhang, Wei-Dong

Targeted Cancer Chemophototherapy: Biomimetic Liposomal Nanoplatinum for Targeted Cancer Chemophototherapy (Adv. Sci. 8/2021)

靶向癌症化疗光疗:用于靶向癌症化疗光疗的仿生脂质体纳米铂(Adv. Sci. 8/2021)

Di, Jin; Price, Jennifer; Gu, Xiao; Jiang, Xiaoning; Jing, Yun; Gu, Zhen; Liu, Xue‐Liang; Dong, Xiao; Yang, Si‐Cong; Lai, Xing; Liu, Hai‐Jun; Gao, Yuhao; Feng, Hai‐Yi; Zhu, Mao‐Hua; Yuan, Yihang; Lu, Qin; Lovell, Jonathan F; Chen, Hong‐Zhuan; Fang, Chao

Inhibition of drug-metabolizing enzymes by Qingfei Paidu decoction: Implication of herb-drug interactions in COVID-19 pharmacotherapy

清肺排毒汤对药物代谢酶的抑制作用:中药与药物相互作用在新冠肺炎药物治疗中的意义

Zhang, Feng; Huang, Jian; Liu, Wei; Wang, Chao-Ran; Liu, Yan-Fang; Tu, Dong-Zhu; Liang, Xin-Miao; Yang, Ling; Zhang, Wei-Dong; Chen, Hong-Zhuan; Ge, Guang-Bo